Barni S, Venturini M, Beretta G D, Gori S, Molino A, Carnaghi C, Labianca R, Sgarbi S, Simoni L, Maiello E
Oncologia Medica, Azienda Ospedaliera, Treviglio, Milan, Italy.
Ann Oncol. 2007 Jun;18 Suppl 6:vi179-84. doi: 10.1093/annonc/mdm252.
RIGHT (Research for the Identification of the most effective and hIGhly accepted clinical guidelines for the cancer Treatment) is a project promoted by the Italian Association of Medical Oncology (AIOM) to measure the concordance between oncology guidelines and clinical practice. The goal of this pilot phase was to develop and test a reliable process to measure this concordance nationwide.
Twenty Italian centers participated to the survey. Breast cancer (BC) and colorectal cancer (CRC): guidelines issued by AIOM in 2003 were selected. A total of 29 indicators linked to the process of care were abstracted. Patients who had their first visit at the oncology center between February 2004 and June 2005, with a diagnosis of invasive BC (stage 1 or 2), colon cancer (stage 3), rectal cancer (stage T3-4 or N1-2) or advanced CRC were enclosed.
One hundred and sixty-one patients (80%) were analyzed. On average, 93% of BC and 80.3% of colorectal patients received recommended care. These first results indicate that the RIGHT system provides a valid measurement of oncology care to assess agreement with guidelines. A second larger phase of this nationwide monitoring program will enable results to be generalized.
RIGHT(癌症治疗最有效且高度可接受临床指南识别研究)是由意大利医学肿瘤学协会(AIOM)推动的一个项目,旨在衡量肿瘤学指南与临床实践之间的一致性。该试点阶段的目标是开发并测试一个在全国范围内衡量这种一致性的可靠流程。
20个意大利中心参与了该调查。乳腺癌(BC)和结直肠癌(CRC):选取了AIOM在2003年发布的指南。共提取了29项与护理流程相关的指标。纳入了2004年2月至2005年6月期间在肿瘤中心首次就诊,诊断为浸润性乳腺癌(1期或2期)、结肠癌(3期)、直肠癌(T3 - 4期或N1 - 2期)或晚期结直肠癌的患者。
对161名患者(80%)进行了分析。平均而言,93%的乳腺癌患者和80.3%的结直肠癌患者接受了推荐的护理。这些初步结果表明,RIGHT系统为评估与指南的一致性提供了有效的肿瘤护理测量方法。这个全国性监测项目的第二个更大规模阶段将使结果能够推广。